Appointment of CEO and board changes

Summary by AI BETAClose X

EDX Medical appointed Martin Walton as CEO with immediate effect on 17 November 2026; he brings more than 35 years' finance experience and 15 years as an investor/officer in life sciences. Co-founder Dr Michael Hudson stepped down from the board effective close of business on 16 November 2026 but will continue as a consultant and Director, International Strategy & Partnerships. Founder Professor Sir Christopher Evans was appointed Deputy Chairman and the board says it has recently added three independent non-executive directors to strengthen governance as the company advances a growth-focused commercial phase.

Disclaimer*

UK 100

Latest directors dealings